The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response

被引：2

作者：

Jeon, E. K. ^{[1
]}

Lim, J. ^{[2
]}

Kim, M. ^{[2
]}

Yahng, S-A ^{[3
]}

Lee, S-E ^{[3
]}

Cho, B-S ^{[3
]}

Kim, Y-J ^{[3
]}

Kim, H-J ^{[3
]}

Min, C-K ^{[3
]}

Cho, S-G ^{[3
]}

Kim, D-W ^{[3
]}

Lee, J-W ^{[3
]}

Min, W-S ^{[3
]}

Park, C-W ^{[3
]}

Lee, S. ^{[3
]}

机构：

[1] Catholic Univ Korea, Coll Med, Dept Oncol, Seoul, South Korea

[2] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea

[3] Catholic Univ Korea, Coll Med, Dept Hematol, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea

来源：

LEUKEMIA | 2011年 / 25卷 / 02期

关键词：

CHRONIC MYELOID-LEUKEMIA; BCR/ABL; JUNCTION;

D O I：

10.1038/leu.2010.265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：366 / 367

页数：2

共 8 条

[1] E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib [J].

Bennour, Ayda ;

Beaufils, Nathalie ;

Sennana, Halima ;

Meddeb, Balkis ;

Saad, Ali ;

Gabert, Jean .

JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (08) :737-740

[2] Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts [J].

Lee, JJ ;

Kim, HJ ;

Kim, YJ ;

Lee, S ;

Hwang, JY ;

Kim, YL ;

Kim, DW .

LEUKEMIA, 2004, 18 (09) :1539-1540

[3] The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Lee, S ;

Kim, YJ ;

Min, CK ;

Kim, HJ ;

Eom, KS ;

Kim, DW ;

Lee, JW ;

Min, WS ;

Kim, CC .

BLOOD, 2005, 105 (09) :3449-3457

[4] Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation [J].

Oshikawa, Gaku ;

Kurosu, Tetsuya ;

Arai, Ayako ;

Murakami, Naomi ;

Miura, Osamu .

CANCER GENETICS AND CYTOGENETICS, 2010, 199 (01) :56-61

[5] BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations [J].

Pane, F ;

Intrieri, M ;

Quintarelli, C ;

Izzo, B ;

Muccioli, GC ;

Salvatore, F .

ONCOGENE, 2002, 21 (56) :8652-8667

[6] Neutrophilic-chronic myeloid leukemia: A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) [J].

Pane, F ;

Frigeri, F ;

Sindona, M ;

Luciano, L ;

Ferrara, F ;

Cimino, R ;

Meloni, G ;

Saglio, G ;

Salvatore, F ;

Rotoli, B .

BLOOD, 1996, 88 (07) :2410-2414

[7] Y253H mutation appearing in a μ-BCR-ABL (e19a2) CML [J].

Popovici, Cornel ;

Charbonnier, Aude ;

Gisserot, Olivier ;

Aguilon, Philippe ;

Remy, Virginie ;

Olschwang, Sylviane ;

Mozziconacci, Marie-Joelle .

LEUKEMIA RESEARCH, 2008, 32 (02) :361-362

[8]

SAGLIO G, 1990, BLOOD, V76, P1819

← 1 →